Deighton C, O'Mahony R, Tosh J, Turner C, Rudolf M; Guideline Development Group. Management of rheumatoid arthritis: summary of NICE guidance. BMJ. 2009 Mar 16;338:b702. doi: 10.1136/bmj.b702.
Donahue KE, Gartlehner G, Jonas DE, Lux LJ, Thieda P, Jonas BL, et al. Systematic review: comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis. Ann Intern Med. 2008 Jan 15;148(2):124-34. Epub 2007 Nov 19.
Firestein GS. . Etiology and pathogenesis of...
Read moreUPDATE ON BIOLOGICAL AGENTS FOR RHEUMATOID ARTHRITIS FROM THE AMERICAN COLLEGE OF RHEUMATOLOGY (ACR) ANNUAL MEETING, 2008 I recently wrote... Read more »
Autumn is here. Whether it is because we are cold, or we sense the never-ending cycle of life heading into its dormant period, it is not... Read more »
Most U.S. rheumatologists would agree that the standard of care when it comes to treating rheumatoid arthritis in is: If a rheumatoid... Read more »
Rheumatoid arthritis is a chronic inflammatory disorder that has no cure. It is an autoimmune disorder, in which the patient’s own... Read more »
IS THE LOWLY TABLET IN FOR A COMEBACK FOR RHEUMATOID ARTHRITIS? It was interesting to read that in August, Pipex Pharmaceuticals, Inc.... Read more »
Disease-modifying antirheumatic drugs (DMARDs), glucocorticoids, and biologics all work to significantly reduce X-ray evidence of joint damage,... Read more »
From the FDA Consumer Magazine, March-April 2005 by Carol Rados Few people with arthritis would be willing to stop taking a medication that works,... Read more »
Biomarkers that can be detected before women develop rheumatoid arthritis have been identified by U.S. researchers. Read more »
Source: ADAM Encyclopedia
Disease-Modifying Anti-Rheumatic Drugs (DMARDs)Disease-modifying anti-rheumatic drugs (DMARDs) are the standard treatments for RA. They are used... Read more »
Rheumatoid and psoriatic arthritis are among the most disabling forms of arthritis. Rheumatoid arthritis (RA), which affects 1 percent of the U.S.... Read more »